Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[Clinical impact of PET/CT on the management of patients with intrahepatic cholangiocarcinoma].

Hatano E, Seo S, Takemoto K, Kitamura K, Machimoto T, Ishii T, Taura K, Higashi T, Nakamoto Y, Uemoto S.

Nihon Shokakibyo Gakkai Zasshi. 2012 Nov;109(11):1878-84. Japanese. No abstract available.

PMID:
23132031
2.

Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.

Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, Lee SS, Seo DW, Lee SK.

Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x.

PMID:
18177454
3.

CT features of intraductal intrahepatic cholangiocarcinoma.

Lee JW, Han JK, Kim TK, Kim YH, Choi BI, Han MC, Suh KS, Kim SW.

AJR Am J Roentgenol. 2000 Sep;175(3):721-5.

PMID:
10954456
4.

Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.

Moon CM, Bang S, Chung JB, Park SW, Song SY, Yun M, Lee JD.

J Gastroenterol Hepatol. 2008 May;23(5):759-65.

PMID:
17931372
5.

Imaging of intrahepatic and hilar cholangiocarcinoma.

Choi BI, Lee JM, Han JK.

Abdom Imaging. 2004 Sep-Oct;29(5):548-57. Review. No abstract available.

PMID:
15185025
6.

[18F-FDG PET/CT in staging and restaging cholangiocarcinoma].

Notaristefano A, Niccoli Asabella A, Stabile Ianora AA, Merenda N, Moschetta M, Antonica F, Altini C, Ferrari C, Cesarano E, Rubini G.

Recenti Prog Med. 2013 Jul-Aug;104(7-8):328-35. doi: 10.1701/1315.14570. Review. Italian.

PMID:
24042402
7.

Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.

Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA.

J Hepatol. 2006 Jul;45(1):43-50.

PMID:
16690156
8.
9.

Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.

Filippi L, Pelle G, Cianni R, Scopinaro F, Bagni O.

Nucl Med Biol. 2015 Jan;42(1):59-64. doi: 10.1016/j.nucmedbio.2014.08.011.

PMID:
25213104
10.

Intrahepatic biloma: an unusual complication of cholangiocarcinoma treated endoscopically.

Ranjeev P, Goh KL, Rosmawati M, Tan YM.

Gastrointest Endosc. 1999 Nov;50(5):711-3. Review. No abstract available.

PMID:
10536338
11.

Value of PET/CT in the management of primary hepatobiliary tumors, part 2.

Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM.

AJR Am J Roentgenol. 2011 Aug;197(2):W260-5. doi: 10.2214/AJR.11.6995. Review.

PMID:
21785051
12.

Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.

De Gaetano AM, Rufini V, Castaldi P, Gatto AM, Filograna L, Giordano A, Bonomo L.

Abdom Imaging. 2012 Dec;37(6):983-1003. doi: 10.1007/s00261-012-9845-y. Review.

PMID:
22527152
13.

Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging.

Chang TT, Bourgeois AC, Balius AM, Pasciak AS.

J Vasc Interv Radiol. 2013 Mar;24(3):333-7. doi: 10.1016/j.jvir.2012.12.005.

PMID:
23433408
14.

Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.

Regimbeau JM, Panis Y, Nemeth J, Pocard M, de Claviere G, Soyer P, Valleur P.

Hepatogastroenterology. 2003 Jan-Feb;50(49):21-3.

PMID:
12629982
15.

[Computed tomographic diagnosis of intrahepatic cholangiocarcinoma].

Hua X, Fu X, Hao Z, Fu Q, Shang H, Chi D.

Zhonghua Yi Xue Za Zhi. 2014 Feb 18;94(6):449-51. Chinese.

PMID:
24754991
16.

[Intramural bile duct varicosis ("pseudo-cholangiocarcinoma sign") in computed tomography].

Strunk H, Textor J, Remig J.

Rofo. 2001 Aug;173(8):765-6. German. No abstract available.

PMID:
11570249
17.

FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.

Ruys AT, Bennink RJ, van Westreenen HL, Engelbrecht MR, Busch OR, Gouma DJ, van Gulik TM.

HPB (Oxford). 2011 Apr;13(4):256-62. doi: 10.1111/j.1477-2574.2010.00280.x.

18.

Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography.

Berr F, Wiedmann M, Mössner J, Tannapfel A, Schmidt F.

Hepatology. 1999 Feb;29(2):611-3. No abstract available.

PMID:
10026030
19.

[Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].

Kim JO, Jun DW, Jang K.

Korean J Gastroenterol. 2013 Aug 25;62(2):135-9. Korean. No abstract available.

20.

Positron emission tomography is not a reliable method for the early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Fevery J, Buchel O, Nevens F, Verslype C, Stroobants S, Van Steenbergen W.

J Hepatol. 2005 Aug;43(2):358-60. No abstract available.

PMID:
15975687
Items per page

Supplemental Content

Support Center